George Yoo is a Head & Neck physician affiliated with Wayne State University. OpenAlex indexes 118 publications with 3,356 citations (h-index 34); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
Sponsor: Barbara Ann Karmanos Cancer Institute
- S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
Sponsor: SWOG Cancer Research Network
- S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat
Sponsor: SWOG Cancer Research Network
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2003–2004 per NIH RePORTER. The latest:
- Enhancement of Ad-p53 Therapy with Intratumoral Taxane
Wayne State University
FY2004$151,000R21DE014878 - Enhancement of Ad-p53 Therapy with Intratumoral Taxane
Wayne State University
FY2003$151,000R21DE014878
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Using telemedicine to facilitate social distancing in otolaryngology: A systematic review
Journal of Telemedicine and Telecare
2021 - Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma
Journal of Clinical Medicine
2019 - Targeting the unfolded protein response in head and neck and oral cavity cancers
Experimental Cell Research
2019 - PD1/PD-L1 inhibition as a potential radiosensitizer in head and neck squamous cell carcinoma: a case report
Journal for ImmunoTherapy of Cancer
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Pranatharthi Chandrasekar, MD
Wayne State University
Bret Hughes, MD
Wayne State University
Mark Juzych, MD, MHSA
Wayne State University
Lubina Arjyal, MD
Wayne State University
Everett Vokes, MD
University of Chicago
Maura Gillison, MD
The University of Texas MD Anderson Cancer Center
Christine Chung, MD
Moffitt Cancer Center
Tanguy Seiwert, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”